Jump to main content
Jump to site search


Phenylethynyl-substituted heterocycles inhibit cyclin D1 and induce the expression of cyclin-dependent kinase inhibitor p21Wif1/Cip1 in colorectal cancer cells

Author affiliations

Abstract

Fluorinated phenylethynyl-substituted heterocycles that possessed either an N-methylamino or N,N-dimethylamino group attached to heterocycles including pyridines, indoles, 1H-indazoles, quinolines, and isoquinolines inhibited the proliferation of LS174T colon cancer cells in which the inhibition of cyclin D1 and induction of the cyclin-dependent kinase inhibitor-1 (i.e., p21Wif1/Cip1) served as readouts for antineoplastic activity at a cellular level. At a molecular level, these agents, particularly 4-((2,6-difluorophenyl)ethynyl)-N-methylisoquinolin-1-amine and 4-((2,6-difluorophenyl)ethynyl)-N,N-dimethylisoquinolin-1-amine, bound and inhibited the catalytic subunit of methionine S-adenosyltransferase-2 (MAT2A).

Graphical abstract: Phenylethynyl-substituted heterocycles inhibit cyclin D1 and induce the expression of cyclin-dependent kinase inhibitor p21Wif1/Cip1 in colorectal cancer cells

Back to tab navigation

Publication details

The article was received on 31 Jul 2017, accepted on 30 Oct 2017 and first published on 03 Nov 2017


Article type: Research Article
DOI: 10.1039/C7MD00393E
Citation: Med. Chem. Commun., 2018, Advance Article
  •   Request permissions

    Phenylethynyl-substituted heterocycles inhibit cyclin D1 and induce the expression of cyclin-dependent kinase inhibitor p21Wif1/Cip1 in colorectal cancer cells

    V. M. Sviripa, L. M. Kril, W. Zhang, Y. Xie, P. Wyrebek, L. Ponomareva, X. Liu, Y. Yuan, C. Zhan, D. S. Watt and C. Liu, Med. Chem. Commun., 2018, Advance Article , DOI: 10.1039/C7MD00393E

Search articles by author

Spotlight

Advertisements